6058
H.-T. Yang et al. / Tetrahedron Letters 51 (2010) 6056–6059
Kitamura, H.; Kokubo, K.; Oshima, T. Org. Lett. 2007, 9, 4045; (g) Ioutsi, V. A.;
Zadorin, A. A.; Khavrel, P. A.; Belov, N. M.; Ovchinnikova, N. S.; Goryunkov, A.
A.; Kharybin, O. N.; Nikolaev, E. N.; Yurovskaya, M. A.; Sidorov, L. N. Tetrahedron
2010, 66, 3037; (h) Wang, G.-W.; Yang, H.-T.; Wu, P.; Miao, C.-B.; Xu, Y. J. Org.
Chem. 2006, 71, 4346; (i) Wang, G.-W.; Yang, H.-T. Tetrahedron Lett. 2007, 48,
4635.
R
R
C
C
N
N
A
A
N
O
A
R
Ph
PhI(OAc)2
-HOAc
C60
R
N
H
-HOAc
-PhI
C
H
I
O
C
H
A
2 or 4
A = O or ArN
1 or 3
2. Martín, N.; Altable, M.; Filippone, S.; Martín-Domenech, A.; Martínez-Alvarez,
R.; Suarez, M.; Plonska-Brzezinska, M. E.; Lukoyanova, O.; Echegoyen, L. J. Org.
Chem. 2007, 72, 3840.
Scheme 2.
3. Illescas, B. M.; Martín, N. J. Org. Chem. 2000, 65, 5986.
4. Meier, M. S.; Poplawska, M. J. Org. Chem. 1993, 58, 4524.
group. The electronic property of the substituent group on the phe-
nyl ring had little influence on the reaction. It is an easy and effi-
cient method to prepare fulleroisoxazolines directly from
aldoximes.
5. (a) Meier, M. S. Tetrahedron 1996, 52, 5043; (b) Meier, M. S.; Poplawska, M. J.
Am. Chem. Soc. 1994, 114, 7044; (c) Perez, L.; El-Khouly, M. E.; de la Cruz, P.;
Araki, Y.; Ito, O.; Langa, F. Eur. J. Org. Chem. 2007, 2175; (d) Langa, F.; de la Cruz,
P.; Espíldora, E.; González-Cortés, A.; de la Hoz, A.; López-Arza, V. J. Org. Chem.
2000, 65, 8675; (e) Illescas, B.; Rife, J.; Ortuno, R. M.; Martín, N. J. Org. Chem.
2000, 65, 6246; (f) Irngartinger, H.; Weber, A.; Escher, T. Eur. J. Org. Chem. 2000,
1647; (g) Delgado, J. L.; Cardinali, F.; Espildora, E.; Torres, M. R.; Langa, F.;
Martín, N. Org. Lett. 2008, 10, 3705; (h) Oswald, F.; de la Cruz, P.; Langa, F.
Synlett 2007, 1051; (i) Gouloumis, A.; Oswald, F.; El-Khouly, M. E.; Langa, F.;
Araki, Y.; Ito, O. Eur. J. Org. Chem. 2006, 2344; (j) Langa, F.; Gomez-Escalonilla,
M. J.; Rueff, J.-M.; Duarte, T. M. F.; Nierengarten, J.-F.; Palermo, V.; Samori, P.;
Rio, Y.; Accorsi, G.; Armaroli, N. Chem. Eur. J. 2005, 11, 4405; (k) Modin, J.;
Johansson, H.; Grennberg, H. Org. Lett. 2005, 7, 3977; (l) Gomez-Escalonilla, M.
J.; Langa, F.; Rueff, J.-M.; Oswald, L.; Nierengarten, J.-F. Tetrahedron Lett. 2002,
43, 7507; (m) Espildora, E.; Delgado, J. L.; de la Cruz, P.; de la Hoz, A.; Lopez-
Arza, V. Tetrahedron 2002, 58, 5821.
Encouraged by these results, we further extended the
PhI(OAc)2-mediated 1,3-dipolar reaction to hydrazones 3a–e and
C60 (Scheme 1). When a mixture of C60 (36.0 mg), hydrazones
3a–e (1 equiv), and PhI(OAc)2 (1 equiv) was stirred in 20 mL tolu-
ene for a designated time at room temperature, fulleropyrazolines
4a–e could also be obtained (Table 1). Yields were fair to good. The
substituent group R2 or R3 on the phenyl ring had little influence
on the yield. This makes it clear that PhI(OAc)2 is a very good oxi-
dant to mediate the 1,3-dipolar reaction of C60 with hydrazones or
aldoximes. A plausible mechanism for the generation of nitrile oxi-
des and nitrile imines is illustrated in Scheme 2.
6. de la Cruz, P.; Diaz_Ortiz, A.; Garcia, J. J.; Gomez_Escalonilla, M. J.; de la Hoz, A.;
Langa, F. Tetrahedron Lett. 1999, 40, 1587.
7. (a) Ohno, M.; Yashiro, A.; Eguchi, S. Synlett 1996, 815; (b) Ohno, M.; Yashiro, A.;
Tsunenishi, Y.; Eguchi, S. Chem. Commun. 1999, 827.
All of the known products were confirmed by comparison of
their spectral data with those reported in the literature. The iden-
tification of new compounds 2c–e, 2h, and 4b was fully confirmed
by their MS, 1H NMR, 13C NMR, FT-IR, and UV–vis spectra. Take 2c
as an example. The MALDI-TOF mass spectrum of 2c showed the
molecular ion peak at m/z 853. The 1H NMR spectrum of 2c dis-
played two doublets at 7.31 and 8.03 ppm for the phenyl ring
and a singlet at 2.44 ppm for the CH3 group. In the 13C NMR spec-
trum of 2c there were 34 peaks in the range of 126–148 ppm due
to the sp2 carbons of the C60 skeleton and phenyl ring and two
peaks at about 72 and 102 ppm for the two sp3 carbons of the
C60 along with a peak at 153.18 ppm for the C@N, fully consistent
with the Cs symmetry of its molecular structure. The UV–vis spec-
trum of 2b exhibited a peak at 427 nm, which is a diagnostic
absorption for the mono-adduct of C60 at the 6:6-junction. The
other new compounds (2c–e, 2h, and 4b) were characterized in a
similar way.
8. Irngartinger, H.; Weber, A.; Escher, T. Liebigs Ann. 1996, 1845.
9. (a) Wang, G.-W.; Li, F.-B. Org. Biomol. Chem. 2005, 3, 794; (b) Li, C.; Zhang, D.;
Zhang, X.; Wu, S.; Gao, X. Org. Biomol. Chem. 2004, 2, 3464; (c) Wang, G.-W.;
Yang, H.-T.; Miao, C.-B.; Xu, Y.; Liu, F. Org. Biomol. Chem. 2006, 4, 2595.
10. (a) Zhdankin, V. V.; Stang, P. J. Chem. Rev. 2002, 2523; (b) Müller, P.; Fruit, C.
Chem. Rev. 2003, 103, 2905; (c) Zhdankin, V. V.; Stang, P. J. Chem. Rev. 2008,
5299.
11. (a) Song, L.-P.; Zhu, S.-Z. J. Fluorine Chem. 2003, 124, 211; (b) Xia, M.; Pan, X.-J.
Synth. Commun. 2004, 34, 3521; (c) Huang, X.; Zhu, Q. Synth. Commun. 2001, 31,
111.
12. (a) Das, B.; Holla, H.; Mahender, G.; Banerjee, J.; Reddy, R. Tetrahedron Lett.
2004, 45, 7347; (b) Das, B.; Holla, H.; Mahender, G.; Venkateswarlu, K.;
Bandgar, B. P. Synthesis 2005, 1572.
13. Zhang, X.; Gan, L.; Huang, S.; Shi, Y. J. Org. Chem. 2004, 69, 5800.
14. Mendelsohn, B. A.; Lee, S.; Kim, S.; Teyssier, F.; Aulakh, V. S.; Ciufolini, M. A. Org.
Lett. 2009, 11, 1539.
15. Typical procedure for the synthesis of fulleroisoxazolines
2
and
fulleropyrazolines 4: a mixture of C60 (36.0 mg, 0.05 mmol), aldoximes 1 or
hydrazones 3 (0.05 mmol), and PhI(OAc)2 (0.05 mmol) was dissolved in 20 mL
of toluene and stirred at room temperature for a desired time. The solvent was
then evaporated in vacuo, and the residue was separated on a silica gel column
using CS2 or CS2–toluene as the eluent to afford unreacted C60 and adduct 2 or
4. Compound 2a: 1H NMR (500 MHz, CS2–CDCl3) d 8.15–8.13 (m, 2H), 7.52–7.50
(m, 3H); 2b: 1H NMR (500 MHz, CS2–CDCl3) d 8.12 (d, J = 8.8 Hz, 2H), 7.02 (d,
J = 8.8 Hz, 2H), 3.86 (s, 3H); 2c: 1H NMR (500 MHz, CS2–CDCl3) d 8.03 (d,
J = 8.2 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 2.44 (s, 3H); 13C NMR (125 MHz, CS2–
CDCl3, all 2C unless indicated) d 153.18 (1C, C@N), 147.72 (1C), 147.22 (1C),
146.36, 146.23, 146.21, 145.96, 145.90, 145.89, 145.58, 145.39, 145.19, 145.11,
144.88, 144.78, 144.62, 144.39, 144.07, 142.97, 142.82 (4C), 142.45 (4C),
142.32, 142,27, 142.09, 141.68, 140.78 (1C, aryl C), 140.29, 140.27, 136.98,
136.64, 129.76 (aryl C), 128.83 (aryl C), 126.23 (1C, aryl C), 104.01 (1C, sp3-C of
In summary, we have explored a useful procedure for the syn-
thesis of fulleroisoxazolines/fulleropyrazolines from fullerene and
aldoximes/hydrazones mediated by PhI(OAc)2, which represents
a significant improvement over existing methods. It is practical
with many advantages such as one-step reaction, no demanding
anhydrous operation, short reaction time, and wide utility.
C
60), 79.29 (1C, sp3-C of C60), 21.63 (1C, CH3); UV–vis (CHCl3) kmax nm 256, 316,
427, 679; FT-IR
/cmÀ1 (KBr) 2919, 2852, 1509, 1300, 1183, 979, 864, 813, 619,
Acknowledgments
m
569, 526; MS (MALDI-TOF) m/z 853; 2d: 1H NMR (500 MHz, CS2–CDCl3) d 8.13
(d, J = 8.6 Hz, 2H), 7.49 (d, J = 8.6 Hz, 2H); 13C NMR (125 MHz, CS2–CDCl3, all 2C
unless indicated) d 153.28 (1C, C@N), 147.74 (1C), 147.24 (1C), 146.38, 146.25,
146.23, 145.97, 145.92, 145.83, 145.61, 145.39, 145.21, 145.13, 144.76, 144.72,
144.47, 144.39, 144.07, 142.98, 142.84 (4C), 142.46 (4C), 142.32, 142,27,
142.09, 141.70, 140.33, 140.30, 137.02, 136.65, 130.61(1C, aryl C), 129.09 (1C,
aryl C), 129.03 (aryl C), 128.87 (aryl C), 104.16 (1C, sp3-C of C60), 79.21 (1C, sp3-
The authors are grateful for the financial support from the Na-
tional Natural Science Foundation of China (Nos. 20902039 and
20872051) and Natural Science Foundation of Jiangsu Province
(BK2009543).
C of C60); UV–vis (CHCl3) kmax nm 256, 317, 427, 678; FT-IR m
/cmÀ1 (KBr) 2921,
Supplementary data
2852, 1506, 1303, 1180, 1094, 979, 862, 823, 570, 526; MS (MALDI-TOF) m/z
873; 2e: 1H NMR (500 MHz, CS2–CDCl3) d 8.44 (d, J = 9.0 Hz, 2H), 8.37 (d,
J = 8.9 Hz, 2H); 13C NMR (125 MHz, CS2–CDCl3, all 2C unless indicated) d 151.86
(1C, C@N), 148.90 (1C, aryl C), 147.77 (1C), 147.31 (1C), 146.44, 146.30 (4C),
146.04, 145.98, 145.73, 145.28 (6C), 145.16, 144.55, 144.41, 144.00, 143.78,
143.69, 143.04, 142.93, 142.91, 142.49 (4C), 142.24 (4C), 141.98, 141.73,
140.45, 140.41, 137.31, 136.58, 135.17 (1C, aryl C), 129.59 (aryl C), 124.09 (aryl
C), 105.14, (1C, sp3-C of C60), 78.19 (1C, sp3-C of C60); UV–vis (CHCl3) kmax nm
Supplementary data associated with this article can be found, in
References and notes
256, 317, 426, 678; FT-IR m
/cmÀ1 (KBr) 2920, 2852, 1511, 1338, 1304, 1181,
1. For book, see: (a) Hirsch, A.; Brettreich, M. Fullerenes: Chemistry and Reactions;
Wiley-VCH Verlag GmbH & Co.: KGaA, 2005; (b) Langa, F.; Nierengarten, J.-F.
Fullerenes: Principles and Applications; RSC Publishing, 2007; For review, see: (c)
Hirsch, A. Synthesis 1995, 895; (d) Yurovskaya, M. A.; Trushkov, I. V. Russ. Chem.
Bull. Int. Ed. 2002, 51, 367; For some recent papers see: (e) Liu, F.; Du, W.; Liang,
Q.; Wang, Y.; Zhang, J.; Zhao, J.; Zhu, S. Tetrahedron Lett. 2010, 66, 5467; (f)
1105, 982, 846, 770, 747, 688, 606, 526; MS (MALDI-TOF) m/z 884; 2f: 1H NMR
(500 MHz, CS2–CDCl3) d 7.65 (d, J = 1.8 Hz, 1H), 7.38 (d, J = 3.5 Hz, 1H), 6.63 (dd,
J = 3.5, 1.8 Hz, 1H); 2g: 1H NMR (500 MHz, CS2–CDCl3) d 2.74 (s, 3H); 2h: 1H
NMR (500 MHz, CS2–CDCl3) d 5.38 (sept, J = 6.2 Hz, 1H), 1.49 (d, J = 6.2 Hz, 6H);
13C NMR (125 MHz, CS2–CDCl3, all 2C unless indicated) d 159.10 (1C, COO),